1-MNA Supplement

 

Product name:  1-MNA, 1-Methylnicotinamide chloride

Other name:   1-Methylnicotinamide chloride, 1-MNA Supplement, 1-MNA chloride

3‑carbamoyl‑1‑methylpyridinium chloride

CAS number:    1005-24-9

Appearance:     White powder

MF:             C7H9N2OCl

MW:            172.61

Specification:   1-Methylnicotinamide chloride 98.5% by HPLC

 

1-MNA Supplement

What is 1-MNA Supplement?

 

1-MNA (1‑ Methylnicotinamide, commonly supplied as its chloride salt, CAS 1005‑24‑9) is a quaternary pyridinium cation and an endogenous metabolite of nicotinamide (vitamin B₃) within the mammalian NAD⁺ metabolic network.

 

It is a water‑soluble white crystalline powder, widely used as a dietary supplement ingredient. Unlike NMN, 1‑MNA supports vascular health via promoting prostacyclin release and shows anti‑inflammatory activity. It has obtained EFSA novel food approval for supplement use.

 

How Does 1-MNA Work?

 

1-MNA supplement works through multiple mechanisms, with its core effects concentrated in two areas: regulating the inflammatory response and protecting vascular endothelial function. Additionally, some emerging evidence suggests it may also influence cellular aging-related pathways through mechanisms distinct from traditional NAD+ precursors.

 

Anti-inflammatory: Scavenging ROS and Inhibiting the NLRP3 Inflammasome

In human macrophages, 1-MNA specifically inhibits activation of the NLRP3 inflammasome, reducing the release of the pro-inflammatory factor IL-1β. This effect is achieved through scavenging reactive oxygen species (ROS): exogenous supplementation with hydrogen peroxide can reverse the inhibitory effect of 1-MNA on the inflammasome. Meanwhile, 1-MNA increases mitochondrial membrane potential without inhibiting oxidative phosphorylation, suggesting its mechanism is not through broadly suppressing cellular metabolism.

 

Another perspective on the anti-inflammatory mechanism involves the concept of “mitohormesis.” 1-MNA can be further metabolized by aldehyde oxidase (AOX), and this process produces small amounts of hydrogen peroxide. This mild pro-oxidative stimulation is believed to activate the innate immune response in a “hormetic” manner, rather than simply suppressing inflammation.

 

Vascular protection: Improving endothelial function through multiple pathways

1-MNA’s protective effects on blood vessels have been validated in multiple human and animal studies, with the core being enhancement of endothelial function:

 

Nitric oxide (NO) pathway: In a randomized controlled trial of healthy individuals and hypercholesterolemic patients, oral 1-MNA significantly improved flow-mediated dilation (FMD) of the brachial artery, and this effect could be almost completely blocked by an nitric oxide synthase inhibitor (L-NMMA), indicating that the vasodilation effect depends on NO production.

 

Prostacyclin (PGI2) pathway: Animal studies show that 1-MNA can improve endothelial function dependent on prostacyclin and NO, inhibit platelet activation, and reduce systemic inflammatory burden.

 

ACE2/Ang-(1-7) axis: In atherosclerotic mouse models, long-term 1-MNA treatment reversed impaired endothelium-dependent vasodilation, and this improvement was associated with activation of the ACE2/Ang-(1-7) pathway and an increased L-arginine/ADMA ratio.

 

The currently most substantiated mechanisms of action for 1-MNA are ROS-dependent inhibition of the NLRP3 inflammasome and NO/PGI2-dependent improvement of endothelial function. The Sirtuin/NAD+-related mechanisms await more rigorous experimental verification.

 

What is 1-MNA supplement benefits?

 

Based on existing research, the documented benefits of 1-MNA are primarily concentrated in three areas: improving vascular endothelial function, exerting anti-inflammatory effects, and enhancing exercise tolerance and fatigue in specific populations (such as post-COVID-19 patients). It is important to note that the evidence intensity varies across these benefits, with some derived from small-scale human trials and others primarily from animal or in vitro studies.

 

Vascular and Endothelial Function

This is the area with relatively more human evidence for 1-MNA. A double-blind randomized controlled trial showed that a single oral dose of 1-MNA (100 mg/m² body surface area) significantly improved brachial artery flow-mediated dilation (FMD) in both healthy volunteers and hypercholesterolemic subjects 2 to 4 hours after administration. In hypercholesterolemic subjects, FMD increased from a baseline of approximately 3.8% to approximately 10.6%, and this effect could be almost completely blocked by a nitric oxide synthase inhibitor, indicating that its vasodilation effect depends on the nitric oxide (NO) pathway.

 

In animal studies, 1-MNA demonstrated anti-atherosclerotic effects in atherosclerosis-prone mice, associated with improved prostacyclin- and NO-dependent endothelial function, inhibition of platelet activation, and reduction of systemic inflammation.

 

Anti-inflammatory Effects

1-MNA exhibits immunomodulatory effects at the cellular level. A 2023 study found that in human macrophages, 1-MNA specifically inhibited activation of the NLRP3 inflammasome, reducing the release of the pro-inflammatory factor IL-1β. This effect is achieved through scavenging reactive oxygen species (ROS), as exogenous hydrogen peroxide can reverse the inhibitory effect of 1-MNA.

 

Improvement of Post-COVID-19 Fatigue and Exercise Tolerance

A randomized controlled trial involving 50 post-COVID-19 patients showed that after 1 month of 1-MNA supplementation (58 mg/day), the 6-minute walk distance in the supplementation group increased from 515.18 meters to 557.8 meters (p=0.000034), with 92% of patients showing improvement; meanwhile, the proportion of patients with severe fatigue in the supplementation group was 20%, significantly lower than 56% in the control group. The study authors noted that the comprehensive effects of 1-MNA, including anti-inflammatory and anticoagulant effects, may be beneficial for recovery in patients with persistent fatigue and low exercise tolerance after COVID-19.

 

The above benefits are primarily supported by small-scale studies. The post-COVID-19 trial had a sample size of only 50 participants and was a short-term (1-month) intervention; the vascular function study also had a limited sample size. Additionally, some potential benefits (such as anti-diabetic effects) are currently only supported by animal model data and have not been validated in humans. Overall, 1-MNA has shown promising signals in vascular protection and anti-inflammatory areas, but high-quality evidence from large-scale, long-term clinical trials is still lacking.

 

Differences Between 1-MNA & NMN

 

FEATURE 1-MNA NMN
CHEMICAL NATURE Methylated metabolite

of nicotinamide

Nicotinamide mononucleotide; classic NAD⁺ precursor
PATHWAY POSITION Downstream catabolite

from nicotinamide by NNMT

Direct intermediate in NAD⁺ salvage pathway
CORE MECHANISM mainly inhibits the NLRP3 inflammasome in a ROS-dependent manner and improves endothelial function via NO/PGI₂ pathways Directly converted intracellularly to NAD⁺, expands the NAD⁺ pool, thereby influencing mitochondrial function, DNA repair, and sirtuin activity
REGULATORY STATUS 1-MNA chloride has been approved as a food supplement in the EU since 2018; EFSA has completed its safety assessment Regulatory attitudes vary by country; not approved as a food supplement in the EU or US

 

One-sentence summary:  NMN‘s core value is “directly replenishing NAD⁺,” while 1-MNA’s core value is “anti-inflammation + vascular protection.” Their mechanisms and evidence bases differ, and they cannot substitute for each other.

 

1-MNA Novel food

1-MNA side effects?

 

Based on available safety data, 1-MNA supplement is considered safe at the approved supplemental dose (58 mg/day), with the most authoritative assessment coming from the European Food Safety Authority (EFSA). However, this conclusion is based on the absence of observed adverse effects at this dose, and it does not mean there are no potential side effects at all.

 

Although the supplemental dose is safe, the following points remain noteworthy:

 

High-dose animal signals: At very high doses (500 mg/kg and above) in animal studies, changes in urine pH were observed, which did not resolve during the recovery period. Although this is far above the human supplemental dose, it suggests that 1-MNA is not completely without dose-dependent effects.

 

Potential long-term unknown risks: The EFSA assessment was based primarily on subchronic (91-day) animal studies and short-term human data. The effects of long-term (years) use in humans remain unknown.

 

Special populations lack data: Safety data for pregnant women, lactating women, children, and individuals with severe hepatic or renal impairment are lacking.

 

 

1-MNA supplement recommended dosage

 

For general consumers using 1-MNA as a daily supplement, 58 mg/day is the dosage that has been officially safety-assessed and supported by human trial data. Higher dosages lack long-term safety data support for healthy populations and should not be self-administered.

 

 

WHERE TO BUY HIGH QUALITY 1-MNA (1-Methylnicotinamide chloride)?

 

Purelife bio is a professional & reliable supplier of the raw material of 1-MNA powder.

 

Our specification: 1-MNA≥98.5% by HPLC

 

According to the European Union’s authorization file for novel foods, the official specifications for 1-MNA (1-methylnicotinamide chloride) are clearly defined (purity ≥98.5%, various impurity limits, heavy metals, microbiological indicators, etc.), please see below:

1-MNA Supplement

 

Since the specifications are an integral part of the authorisation conditions, products that do not meet the specifications do not comply with the authorisation and therefore cannot be legally marketed as a novel food.

 

Our 1-MNA meets the official specifications completely. If you need certificate of analysis, MSDS, pricing quotation, test spectrum or have any other technical questions, please kindly drop us an email at info@purelife-bio.com, a timely and professional support will be provided upon your request.